Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-01-01 @ 12:48 PM
Study NCT ID:
NCT04537793
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2020-08-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-28
First Submit QC Date:
None
Study First Post Date:
2020-09-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-02
Results First Submit QC Date:
None
Results First Post Date:
2023-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-02
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL